News & Media

Get news alerts by email

News Releases
Jan 122018

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2018 on February 8 prior to the opening of trading on the New York Stock Exchange. The company...

drug eluding stent
Jan 112018

DUBLIN, Ohio, January 11, 2018 — Cordis, a Cardinal Health company, and Medinol today announced that the first commercial cases using the EluNIR™ drug-eluting stent (DES) in the United States...

Jan 042018

Cardinal Health announced today that Mike Kaufmann, chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, Jan. 8, 2018, at 11 a.m....

Dec 072017

Cardinal Health Specialty Solutions today introduced the second edition of Oncology Insights, a research-based report outlining the views of more than 200 U.S. oncologists on the latest medical...

Nov 302017

Cordis, a Cardinal Health company, and Medinol today announced United States Food and Drug Administration (FDA) approval of the EluNIR™ drug-eluting stent (DES) for the treatment of patients...

See More

Get news alerts by email

Complete the form below to receive e-mail notifications of our news releases. You will receive an email which you must reply to in order to confirm your subscription. You may unsubscribe from our list at anytime.